168 related articles for article (PubMed ID: 22190693)
1. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.
Sharma R; Strelevitz TJ; Gao H; Clark AJ; Schildknegt K; Obach RS; Ripp SL; Spracklin DK; Tremaine LM; Vaz AD
Drug Metab Dispos; 2012 Mar; 40(3):625-34. PubMed ID: 22190693
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde oxidase activity in fresh human skin.
Manevski N; Balavenkatraman KK; Bertschi B; Swart P; Walles M; Camenisch G; Schiller H; Kretz O; Ling B; Wettstein R; Schaefer DJ; Pognan F; Wolf A; Litherland K
Drug Metab Dispos; 2014 Dec; 42(12):2049-57. PubMed ID: 25249692
[TBL] [Abstract][Full Text] [Related]
3. Interspecies variation in the metabolism of zoniporide by aldehyde oxidase.
Dalvie D; Xiang C; Kang P; Zhou S
Xenobiotica; 2013 May; 43(5):399-408. PubMed ID: 23046389
[TBL] [Abstract][Full Text] [Related]
4. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
Crouch RD; Hutzler JM; Daniels JS
Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
[TBL] [Abstract][Full Text] [Related]
5. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Zientek M; Jiang Y; Youdim K; Obach RS
Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
[TBL] [Abstract][Full Text] [Related]
6. Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences.
Dalvie D; Zhang C; Chen W; Smolarek T; Obach RS; Loi CM
Drug Metab Dispos; 2010 Apr; 38(4):641-54. PubMed ID: 20040581
[TBL] [Abstract][Full Text] [Related]
7. Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man.
Kaye B; Rance DJ; Waring L
Xenobiotica; 1985 Mar; 15(3):237-42. PubMed ID: 4024658
[TBL] [Abstract][Full Text] [Related]
8. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
9. Deuterium isotope effects in drug pharmacokinetics II: Substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs.
Sun H; Piotrowski DW; Orr STM; Warmus JS; Wolford AC; Coffey SB; Futatsugi K; Zhang Y; Vaz ADN
PLoS One; 2018; 13(11):e0206279. PubMed ID: 30427871
[TBL] [Abstract][Full Text] [Related]
10. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401.
Zhang JW; Deng HB; Zhang CY; Dai JQ; Li Q; Zheng QG; Wan HX; Yu HP; He F; Xu YC; Zhao S; Zhang JYJ
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):669-680. PubMed ID: 31030415
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.
Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S
Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595
[TBL] [Abstract][Full Text] [Related]
13. Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist.
Stringer RA; Williams G; Picard F; Sohal B; Kretz O; McKenna J; Krauser JA
Drug Metab Dispos; 2014 May; 42(5):954-62. PubMed ID: 24616265
[TBL] [Abstract][Full Text] [Related]
14. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Strelevitz TJ; Orozco CC; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of carbazeran in guinea pig: effect of hydralazine pretreatment.
Critchley DJ; Rance DJ; Beedham C
Xenobiotica; 1994 Jan; 24(1):37-47. PubMed ID: 8165820
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and hepatic disposition of repaglinide in pigs: mechanistic modeling of metabolism and transport.
Sjögren E; Bredberg U; Lennernäs H
Mol Pharm; 2012 Apr; 9(4):823-41. PubMed ID: 22352317
[TBL] [Abstract][Full Text] [Related]
17. Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.
Akabane T; Tanaka K; Irie M; Terashita S; Teramura T
Xenobiotica; 2011 May; 41(5):372-84. PubMed ID: 21385103
[TBL] [Abstract][Full Text] [Related]
18. Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide.
Dalvie D; Sun H; Xiang C; Hu Q; Jiang Y; Kang P
Drug Metab Dispos; 2012 Aug; 40(8):1575-87. PubMed ID: 22587988
[TBL] [Abstract][Full Text] [Related]
19. Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs.
Subash S; Singh DK; Ahire DS; Khojasteh SC; Murray BP; Zientek MA; Jones RS; Kulkarni P; Smith BJ; Heyward S; Cronin CN; Prasad B
Drug Metab Dispos; 2023 Oct; 51(10):1362-1371. PubMed ID: 37429730
[TBL] [Abstract][Full Text] [Related]
20. Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638.
Schofield J; Derdau V; Atzrodt J; Zane P; Guo Z; van Horn R; Czepczor V; Stoltz A; Pardon M
Bioorg Med Chem; 2015 Jul; 23(13):3831-42. PubMed ID: 25900628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
